Evidence map›Paper›PMID 20525077›Full record

ArticleThe European journal of neuroscience2010

The effects of aging and chronic fluoxetine treatment on circadian rhythms and suprachiasmatic nucleus expression of neuropeptide genes and 5-HT1B receptors.

Marilyn J Duncan, James M Hester, Jason A Hopper, Kathleen M Franklin

Open access · greenAbstract read
In one paragraph

Article in The European journal of neuroscience, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Evidence for neuronal desynchrony in the aged suprachiasmatic nucleus clock.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Marilyn J DuncanDepartment of Anatomy and Neurobiology, University of Kentucky Medical Center, Lexington, KY 40536, USA. marilyn.duncan@uky.edu
James M Hester
Jason A Hopper
Kathleen M Franklin
University of Kentucky · US

Funding

NEURAL MECHANISMS RESETTING THE AGED CIRCADIAN PACEMAKERR01AG013418 · NIA · UNIVERSITY OF KENTUCKY · PI DUNCAN, MARILYN J. · 1996 to 2010
$2.8M
NIA NIH HHS AG13418NIA NIH HHS R01 AG013418
6 · The paper itself

Abstract

Age-related changes in circadian rhythms, including attenuation of photic phase shifts, are associated with changes in the central pacemaker in the suprachiasmatic nucleus (SCN). Aging decreases expression of mRNA for vasoactive intestinal peptide (VIP), a key neuropeptide for rhythm generation and photic phase shifts, and increases expression of serotonin transporters and 5-HT(1B) receptors, whose activation inhibits these phase shifts. Here we describe studies in hamsters showing that aging decreases SCN expression of mRNA for gastrin-releasing peptide, which also modulates photic phase resetting. Because serotonin innervation trophically supports SCN VIP mRNA expression, and serotonin transporters decrease extracellular serotonin, we predicted that chronic administration of the serotonin-selective reuptake inhibitor, fluoxetine, would attenuate the age-related changes in SCN VIP mRNA expression and 5-HT(1B) receptors. In situ hybridization studies showed that fluoxetine treatment does not alter SCN VIP mRNA expression, in either age group, at zeitgeber time (ZT)6 or 13 (ZT12 corresponds to lights off). However, receptor autoradiographic studies showed that fluoxetine prevents the age-related increase in SCN 5-HT(1B) receptors at ZT6, and decreases SCN 5-HT(1B) receptors in both ages at ZT13. Therefore, aging effects on SCN VIP mRNA and SCN 5-HT(1B) receptors are differentially regulated; the age-related increase in serotonin transporter sites mediates the latter but not the former. The studies also showed that aging and chronic fluoxetine treatment decrease total daily wheel running without altering the phase of the circadian wheel running rhythm, in contrast to previous reports of phase resetting by acute fluoxetine treatment.

Indexed as

AgingAnimalsCircadian RhythmCricetinaeFluoxetineGastrin-Releasing PeptideMaleMotor ActivityNeuropeptidesPhotoperiodReceptor, Serotonin, 5-HT1BRNA, MessengerSelective Serotonin Reuptake InhibitorsSerotonin Plasma Membrane Transport ProteinsSuprachiasmatic NucleusVasoactive Intestinal PeptideFluoxetineGastrin-Releasing PeptideNeuropeptidesReceptor, Serotonin, 5-HT1BRNA, MessengerSelective Serotonin Reuptake InhibitorsSerotonin Plasma Membrane Transport ProteinsVasoactive Intestinal Peptide

Identifiers

PMID20525077
PMCPMC2957648
OpenAlexW1573549447

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.